Bausch Health Companies | VRX - Current Liabilities

Stock Price
7.77
Daily Change
-0.12 -1.52%
Monthly
-23.90%
Yearly
-25.29%
Q1 Forecast
7.62

Bausch Health Companies reported $4.79B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Amgen USD 21.79B 1.32B Sep/2025
ANI Pharmaceuticals USD 270.56M 33.72M Sep/2025
Aurora Cannabis CAD 124.12M 32.76M Sep/2025
Bausch Health Companies USD 4.79B 182M Sep/2025
Biogen USD 3.29B 106.3M Sep/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Canopy Growth CAD 81.1M 17.56M Sep/2025
Corcept Therapeutics USD 172.26M 27.6M Sep/2025
Danaher USD 6.81B 483M Dec/2025
Drreddys Laboratories INR 1.76B 62.5M Dec/2025
Eli Lilly USD 40.14B 1.12B Sep/2025
Gilead Sciences USD 12.3B 1.11B Sep/2025
Novo Nordisk DKK 234.36B 26.84B Sep/2025
Pacira USD 107.08M 206.09M Sep/2025
Perrigo USD 1.15B 19.2M Sep/2025
Prestige Brands USD 134.6M 24.94M Sep/2025
Supernus Pharmaceuticals USD 330.63M 44.27M Sep/2025
Vertex Pharmaceuticals USD 4.48B 336.9M Sep/2025
Zoetis USD 1.81B 1.56B Sep/2025